Advertisement

Ads Placeholder
Loading...

NervGen Pharma Corp.

NGENF•PNK
Healthcare
Biotechnology
$3.95
$-0.10(-2.47%)
U.S. Market opens in 5h 4m

NervGen Pharma Corp. (NGENF) Stock Overview

Explore NervGen Pharma Corp.’s financial performance, market position, analyst ratings, and future outlook.

Meyka AI Score

Z

Key Financials

Market Cap312.9M
P/E Ratio-15.46
EPS (TTM)$-0.26
ROE-974.60%
Fundamental Analysis

AI Price Forecasts

1 Month$4.14
3 Months$4.45
1 Year Target$7.37

NGENF Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of NervGen Pharma Corp. (NGENF) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

The current technical analysis reveals key indicators including an RSI of 19.46, suggesting the stock is in an oversold condition. Our forecasting models predict significant price movements, with a 12-month target of $7.37.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of -15.46 and a market capitalization of 312.9M. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

1-Day Change
N/A
5-Day Change
N/A
1-Month Change
-4.82%
3-Month Change
-31.30%
6-Month Change
19.34%
Year-to-Date (YTD) Change
-32.82%
1-Year Change
93.63%
3-Year Change
185.82%
5-Year Change
205.51%
All-Time (Max) Change
203.68%

Contact Information

https://www.nervgen.com
778 731 1711
2955 Virtual Way, Vancouver, BC, V5M 4X6

Company Facts

110 Employees
IPO DateApr 3, 2019
CountryCA

Frequently Asked Questions